Perioperative Systemic Chemotherapy for Colorectal Liver Metastasis: Recent Updates
- PMID: 34572817
- PMCID: PMC8464667
- DOI: 10.3390/cancers13184590
Perioperative Systemic Chemotherapy for Colorectal Liver Metastasis: Recent Updates
Abstract
The liver is the most common site of metastases for colorectal cancer. Complete resection in some patients with resectable liver metastases (LM) can lead to long-term survival and cure. Adjuvant systemic chemotherapy after complete resection of LM improves recurrence-free survival; however, the overall survival benefit is not clear. In selected patients, preoperative systemic treatment for metastatic colorectal cancer can convert unresectable to resectable cancer. This review will focus on patient selection, and integration of perioperative and postoperative systemic treatment to surgery in resectable and initially unresectable LM. Additionally, new drugs and biomarkers will be discussed.
Keywords: adjuvant chemotherapy; colorectal neoplasms; liver; metastasis; neoadjuvant therapy.
Conflict of interest statement
The authors declare the absence of any conflict of interest related to the study or its submission for publication.
References
-
- Kemeny N. Management of liver metastases from colorectal cancer. Oncology (Williston Park) 2006;20:1161–1176. - PubMed
-
- Kanas G.P., Taylor A., Primrose J.N., Langeberg W.J., Kelsh M.A., Mowat F.S., Alexander D.D., Choti M.A., Poston G. Survival after liver resection in metastatic colorectal cancer: Review and meta-analysis of prognostic factors. Clin. Epidemiol. 2012;4:283–301. doi: 10.2147/clep.S34285. - DOI - PMC - PubMed
-
- De Ridder J.A.M., Van der Stok E.P., Mekenkamp L.J., Wiering B., Koopman M., Punt C.J.A., Verhoef C., De Wilt J.H. Management of liver metastases in colorectal cancer patients: A retrospective case-control study of systemic therapy versus liver resection. Eur. J. Cancer. 2016;59:13–21. doi: 10.1016/j.ejca.2016.02.003. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
